Cargando…

Specific targeting of the GABA-A receptor α5 subtype by a selective inverse agonist restores cognitive deficits in Down syndrome mice

An imbalance between inhibitory and excitatory neurotransmission has been proposed to contribute to altered brain function in individuals with Down syndrome (DS). Gamma-aminobutyric acid (GABA) is the major inhibitory neurotransmitter in the central nervous system and accordingly treatment with GABA...

Descripción completa

Detalles Bibliográficos
Autores principales:	Braudeau, J, Delatour, B, Duchon, A, Pereira, P Lopes, Dauphinot, L, de Chaumont, F, Olivo-Marin, J-C, Dodd, RH, Hérault, Y, Potier, M-C
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2011
Materias:	Original Papers
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3160204/ https://www.ncbi.nlm.nih.gov/pubmed/21693554 http://dx.doi.org/10.1177/0269881111405366

Ejemplares similares

Chronic Treatment with a Promnesiant GABA-A α5-Selective Inverse Agonist Increases Immediate Early Genes Expression during Memory Processing in Mice and Rectifies Their Expression Levels in a Down Syndrome Mouse Model
por: Braudeau, J., et al.
Publicado: (2011)

Long‐lasting correction of in vivo LTP and cognitive deficits of mice modelling Down syndrome with an α5‐selective GABA(A) inverse agonist
por: Duchon, Arnaud, et al.
Publicado: (2020)

Dosage of the Abcg1-U2af1 Region Modifies Locomotor and Cognitive Deficits Observed in the Tc1 Mouse Model of Down Syndrome
por: Marechal, Damien, et al.
Publicado: (2015)

Pharmacological correction of excitation/inhibition imbalance in Down syndrome mouse models
por: Souchet, Benoit, et al.
Publicado: (2015)

DYRK1A, a Dosage-Sensitive Gene Involved in Neurodevelopmental Disorders, Is a Target for Drug Development in Down Syndrome
por: Duchon, Arnaud, et al.
Publicado: (2016)

Augmentation of Tonic GABA(A) Inhibition in Absence Epilepsy: Therapeutic Value of Inverse Agonists at Extrasynaptic GABA(A) Receptors
por: Errington, Adam C., et al.
Publicado: (2011)

Dyrk1a from Gene Function in Development and Physiology to Dosage Correction across Life Span in Down Syndrome
por: Atas-Ozcan, Helin, et al.
Publicado: (2021)

Gene expression signature of cerebellar hypoplasia in a mouse model of Down syndrome during postnatal development
por: Laffaire, Julien, et al.
Publicado: (2009)

The telomeric part of the human chromosome 21 from Cstb to Prmt2 is not necessary for the locomotor and short-term memory deficits observed in the Tc1 mouse model of Down syndrome
por: Duchon, Arnaud, et al.
Publicado: (2011)

Correction of cognitive deficits in mouse models of Down syndrome by a pharmacological inhibitor of DYRK1A
por: Nguyen, Thu Lan, et al.
Publicado: (2018)

Identification of the translocation breakpoints in the Ts65Dn and Ts1Cje mouse lines: relevance for modeling down syndrome
por: Duchon, Arnaud, et al.
Publicado: (2011)

Ts66Yah, a mouse model of Down syndrome with improved construct and face validity
por: Duchon, Arnaud, et al.
Publicado: (2022)

AM281, Cannabinoid Antagonist/Inverse agonist, Ameliorates Scopolamine-Induced Cognitive Deficit
por: Rabbani, Mohammed, et al.
Publicado: (2012)

β(2)-adrenoreceptor Inverse Agonist Down-regulates Muscarine Cholinergic Subtype-3 Receptor and Its Downstream Signal Pathways in Airway Smooth Muscle Cells in vitro
por: Luo, Jian, et al.
Publicado: (2017)

Interaction of agonists of a different subtype of the nAChR and carvacrol with GABA in Ascaris suum somatic muscle contractions
por: Marjanović, Djordje S., et al.
Publicado: (2021)

Pharmacological Effect of GABA Analogues on GABA-ρ2 Receptors and Their Subtype Selectivity
por: Naffaa, Moawiah M., et al.
Publicado: (2022)

Molecular Characterization of Agonists That Bind to an Insect GABA Receptor†
por: McGonigle, Ian, et al.
Publicado: (2010)

GABA(B)-Agonistic Activity of Certain Baclofen Homologues
por: Attia, Mohamed I., et al.
Publicado: (2013)

Retraction Note: β(2)-adrenoreceptor Inverse Agonist Down-regulates Muscarine Cholinergic Subtype-3 Receptor and Its Downstream Signal Pathways in Airway Smooth Muscle Cells in vitro
por: Luo, Jian, et al.
Publicado: (2019)

Alzheimer disease models and human neuropathology: similarities and differences
por: Duyckaerts, Charles, et al.
Publicado: (2007)

The App-Runx1 Region Is Critical for Birth Defects and Electrocardiographic Dysfunctions Observed in a Down Syndrome Mouse Model
por: Raveau, Matthieu, et al.
Publicado: (2012)

Elucidation of Inverse Agonist Activity of Bilastine
por: Mizuguchi, Hiroyuki, et al.
Publicado: (2020)

Antitussive effects of the peripherally restricted GABA(B) receptor agonist lesogaberan in guinea pigs: comparison to baclofen and other GABA(B) receptor-selective agonists
por: Canning, Brendan J, et al.
Publicado: (2012)

TPA-023 attenuates subchronic phencyclidine-induced declarative and reversal learning deficits via GABA(A) receptor agonist mechanism: possible therapeutic target for cognitive deficit in schizophrenia
por: Rajagopal, Lakshmi, et al.
Publicado: (2018)

An Overview of the CNS-Pharmacodynamic Profiles of Nonselective and Selective GABA Agonists
por: Chen, Xia, et al.
Publicado: (2012)

Anxiolytics for Bronchodilation: Refinements to GABA(A) Agonists for Asthma Relief
por: Nayak, Ajay P., et al.
Publicado: (2022)

Limitations of Current GABA Agonists in Neonatal Seizures: Toward GABA Modulation Via the Targeting of Neuronal Cl(−) Transport
por: Khanna, Arjun, et al.
Publicado: (2013)

Modeling Chromosomes in Mouse to Explore the Function of Genes, Genomic Disorders, and Chromosomal Organization
por: Brault, Véronique, et al.
Publicado: (2006)

cAMP/PKA Agonist Restores the Fasting-Induced Down-Regulation of nNOS Expression in the Paraventricular Nucleus
por: Yoo, Sang Bae, et al.
Publicado: (2012)

Identification of Selective ERRγ Inverse Agonists
por: Kim, Jina, et al.
Publicado: (2016)

GABA(A) Receptor Subtypes: Novel Targets for Novel Medicines
por: Mirza, Naheed R., et al.
Publicado: (2012)

Understanding subtype-selective allosteric modulation of GABA(A) receptors
por: Puthenkalam, Roshan, et al.
Publicado: (2012)

GABA(A) receptor subtype selectivity of the proconvulsant rodenticide TETS
por: Pressly, Brandon, et al.
Publicado: (2017)

GABA(A) receptor subtypes and benzodiazepine use, misuse, and abuse
por: Engin, Elif
Publicado: (2023)

γ-Hydroxybutyric Acid (GHB) Is Not an Agonist of Extrasynaptic GABA(A) Receptors
por: Connelly, William M., et al.
Publicado: (2013)

Shared GABA transmission pathology in dopamine agonist- and antagonist-induced dyskinesia
por: Abe, Yoshifumi, et al.
Publicado: (2023)

GABA-B Agonist Baclofen Normalizes Auditory-Evoked Neural Oscillations and Behavioral Deficits in the Fmr1 Knockout Mouse Model of Fragile X Syndrome
por: Sinclair, D., et al.
Publicado: (2017)

DYRK1A inhibition and cognitive rescue in a Down syndrome mouse model are induced by new fluoro-DANDY derivatives
por: Neumann, Fernanda, et al.
Publicado: (2018)

Rescue of deficits by Brwd1 copy number restoration in the Ts65Dn mouse model of Down syndrome
por: Fulton, Sasha L., et al.
Publicado: (2022)

Behavioral Deficits Induced by Somatostatin-Positive GABA Neuron Silencing Are Rescued by Alpha 5 GABA-A Receptor Potentiation
por: Fee, Corey, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_drt6qa3cnitcvhu5s50hsgvijq